Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical studies with a new podophyllotoxin derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidine- -D-glucopyranoside) (NSC-122819).

× No keyword cloud information.

6 in total

1. Teniposide is not effective in chronic lymphocytic leukemia.

Authors: V Zagonel; U Tirelli; A Veronesi; E Galligioni; S Tumolo; M Roncadin; A Carbone; E Grigoletto
Journal: Blut Date: 1986-01

Review 2. VM26: phase I and II studies.

Authors: F R Macbeth
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

Review 3. The clinical pharmacology of VM26 and VP16-213. A brief overview.

Authors: P J Creaven
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

Review 4. Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors: R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal: Drugs Date: 1978-07 Impact factor: 9.546

5. The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung.

Authors: H Roed; L L Vindelov; I J Christensen; M Spang-Thomsen; H H Hansen
Journal: Cancer Chemother Pharmacol Date: 1987 Impact factor: 3.333

Review 6. Teniposide: overview of its therapeutic potential in adult cancers.

Authors: F M Muggia
Journal: Cancer Chemother Pharmacol Date: 1994 Impact factor: 3.333

6 in total